Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences

Male Genotype Incidence Amyotrophic Lateral Sclerosis Blotting, Western DNA Mutational Analysis Histocompatibility Antigens Class I Membrane Proteins Middle Aged Cytoskeletal Proteins Neuroblastoma 03 medical and health sciences 0302 clinical medicine Gene Frequency Case-Control Studies Cell Line, Tumor Mutation Humans Female Age of Onset Amino Acids Hemochromatosis Protein
DOI: 10.1016/j.jns.2004.08.003 Publication Date: 2004-09-21T18:24:21Z
ABSTRACT
The etiology of amyotrophic lateral sclerosis (ALS) is unknown. The presence of mutations in the superoxide dismutase gene (SOD1) has led to theories regarding a role for oxidative stress in the pathogenesis of this disease. A primary cause of oxidative stress is perturbations in cellular iron homeostasis. Cellular iron mismanagement and oxidative stress are associated with a number of neurodegenerative diseases. One mechanism by which cells fail to properly regulate their iron status is through a mutation in the Hfe gene. Mutations in the Hfe gene are associated with the iron overload disease, hemochromatosis. In the current study, 31% of patients with sporadic ALS carried a mutation in the Hfe gene, compared to only 14% of patients without identifiable neuromuscular disease, or with neuromuscular diseases other than ALS (p<0.005). To determine the cellular consequences of carrying an Hfe mutation, a human neuronal cell line was transfected with genes carrying the Hfe mutation. The presence of the Hfe mutation disrupted expression of tubulin and actin at the protein levels potentially consistent with the disruption of axonal transport seen in ALS and was also associated with a decrease in CuZnSOD1 expression. These data provide compelling evidence for a role for the Hfe mutation in etiopathogenesis of ALS and warrant further investigation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (94)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....